
...in Trondheim is called ‘BubbleCAN’ and is based on SINTEF proprietary technology. Researchers are making stable micro-bubbles containing chemotherapeutic drugs. The bubbles can be used in combination with ultrasound and are highly suitable for inoperable cancers and brain tumours that are difficult to...